Pablo Mozas
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 31
- Oncology 20
- Viral-associated cancers and disorders 16
- Co-authors
- Julio Delgado (17 shared papers)Armando López‐Guillermo (17 shared papers)Alfredo Rivas‐Delgado (14 shared papers)Tycho Baumann (11 shared papers)Andrea Rivero (14 shared papers)Laura Magnano (14 shared papers)Elı́as Campo (16 shared papers)Eva Giné (13 shared papers)
In The Last Decade
Pablo Mozas
33 papers receiving 277 citations
Peers
Comparison fields: 5 of 39
- Pathology and Forensic Medicine 221
- Genetics 126
- Oncology 144
- Reproductive Medicine 35
- Immunology 83
Countries citing papers authored by Pablo Mozas
This map shows the geographic impact of Pablo Mozas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Mozas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Mozas more than expected).
Fields of papers citing papers by Pablo Mozas
This network shows the impact of papers produced by Pablo Mozas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Mozas. The network helps show where Pablo Mozas may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Mozas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 66 | |
| 2 | 2018 | 44 | |
| 3 | 2020 | 25 | |
| 4 | 2021 | 12 | |
| 5 | 2021 | 11 | |
| 6 | 2020 | 11 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2016 | 5 | |
| 20 | 2020 | 5 |
About Pablo Mozas
Pablo Mozas is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Reproductive Medicine, having authored 37 papers that have together received 284 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (31 papers), Viral-associated cancers and disorders (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Ovarian cancer diagnosis and treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers) and Cutaneous lymphoproliferative disorders research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (221 citations), Genetics (126 citations), Oncology (144 citations), Reproductive Medicine (35 citations) and Immunology (83 citations). Pablo Mozas has collaborated with scholars based in Spain, Italy and Czechia. Frequent co-authors include Julio Delgado, Armando López‐Guillermo, Alfredo Rivas‐Delgado, Tycho Baumann, Andrea Rivero, Laura Magnano, Elı́as Campo, Eva Giné, Neus Villamor and Ferran Nadeu. Their work appears in journals such as British Journal of Haematology, Frontiers in Oncology, Hematological Oncology, Blood Reviews and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.